流感疫苗市场动态 - Suppr

Suppr

超能文献

Influenza vaccine market dynamics.

作者信息

Kresse Hedwig, Rovini Holger

机构信息

Hedwig Kresse is Senior Analyst, Infectious Diseases, Datamonitor, 119 Farringdon Road, London, EC1R 3DA, UK.

出版信息

Nat Rev Drug Discov. 2009 Nov;8(11):841-2. doi: 10.1038/nrd3026.

DOI:10.1038/nrd3026

PMID:19876038

Abstract

摘要

相似文献

Influenza vaccine market dynamics.

Nat Rev Drug Discov. 2009 Nov;8(11):841-2. doi: 10.1038/nrd3026.

Legal concerns and the influenza vaccine shortage.

JAMA. 2005 Oct 12;294(14):1817-20. doi: 10.1001/jama.294.14.1817.

Medical countermeasures for pandemic influenza: ethics and the law.

JAMA. 2006 Feb 1;295(5):554-6. doi: 10.1001/jama.295.5.554.

Vaccine shortage for pandemic influenza: can it be solved?

Vaccine. 2006 Apr 5;24(15):2701. doi: 10.1016/j.vaccine.2005.09.038. Epub 2005 Oct 6.

United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing world.

Vaccine. 2011 Jul 1;29 Suppl 1:A48-50. doi: 10.1016/j.vaccine.2011.02.080.

Summaries for patients. Assessing the best way to prevent spread of influenza.

Ann Intern Med. 2009 Dec 15;151(12):I31. doi: 10.7326/0003-4819-151-12-200912150-00161.

[H1N1, pandemics, France and big Pharma].

Rev Med Suisse. 2010 Aug 25;6(259):1564-5.

Universal influenza vaccine: the holy grail?

Expert Rev Vaccines. 2012 Aug;11(8):923-7. doi: 10.1586/erv.12.73.

New influenza vaccines: promises, perils, and pitfalls.

Vaccine. 2012 Feb 1;30(6):983-4. doi: 10.1016/j.vaccine.2011.12.086.

Flu experts rebut conflict claims.

Nature. 2010 Jun 10;465(7299):672-3. doi: 10.1038/465672a.

引用本文的文献

An opportunity to incentivize innovation to increase vaccine safety in the United States by improving vaccine delivery using vaccine patches.

Vaccine. 2020 May 22;38(25):4060-4065. doi: 10.1016/j.vaccine.2020.04.044. Epub 2020 Apr 21.

Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans.

Clin Infect Dis. 2012 Jul;55(1):19-25. doi: 10.1093/cid/cis327. Epub 2012 Mar 22.

Pricing of new vaccines.

Hum Vaccin. 2010 Aug;6(8):619-26. doi: 10.4161/hv.6.8.11563.

Controlling influenza by cytotoxic T-cells: calling for help from destroyers.

J Biomed Biotechnol. 2010;2010:863985. doi: 10.1155/2010/863985. Epub 2010 May 24.

本文引用的文献

Update: influenza vaccine supply and recommendations for prioritization during the 2005-06 influenza season.

MMWR Morb Mortal Wkly Rep. 2005 Sep 2;54(34):850.

Vaccine supply: a cross-national perspective.

Health Aff (Millwood). 2005 May-Jun;24(3):706-17. doi: 10.1377/hlthaff.24.3.706.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Influenza vaccine market dynamics.

Nat Rev Drug Discov. 2009 Nov;8(11):841-2. doi: 10.1038/nrd3026.

Legal concerns and the influenza vaccine shortage.

JAMA. 2005 Oct 12;294(14):1817-20. doi: 10.1001/jama.294.14.1817.

Medical countermeasures for pandemic influenza: ethics and the law.

JAMA. 2006 Feb 1;295(5):554-6. doi: 10.1001/jama.295.5.554.

Vaccine shortage for pandemic influenza: can it be solved?

Vaccine. 2006 Apr 5;24(15):2701. doi: 10.1016/j.vaccine.2005.09.038. Epub 2005 Oct 6.

United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing world.

Vaccine. 2011 Jul 1;29 Suppl 1:A48-50. doi: 10.1016/j.vaccine.2011.02.080.

Summaries for patients. Assessing the best way to prevent spread of influenza.

Ann Intern Med. 2009 Dec 15;151(12):I31. doi: 10.7326/0003-4819-151-12-200912150-00161.

[H1N1, pandemics, France and big Pharma].

Rev Med Suisse. 2010 Aug 25;6(259):1564-5.

Universal influenza vaccine: the holy grail?

Expert Rev Vaccines. 2012 Aug;11(8):923-7. doi: 10.1586/erv.12.73.

New influenza vaccines: promises, perils, and pitfalls.

Vaccine. 2012 Feb 1;30(6):983-4. doi: 10.1016/j.vaccine.2011.12.086.

Flu experts rebut conflict claims.

Nature. 2010 Jun 10;465(7299):672-3. doi: 10.1038/465672a.

引用本文的文献

An opportunity to incentivize innovation to increase vaccine safety in the United States by improving vaccine delivery using vaccine patches.

Vaccine. 2020 May 22;38(25):4060-4065. doi: 10.1016/j.vaccine.2020.04.044. Epub 2020 Apr 21.

Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans.

Clin Infect Dis. 2012 Jul;55(1):19-25. doi: 10.1093/cid/cis327. Epub 2012 Mar 22.

Pricing of new vaccines.

Hum Vaccin. 2010 Aug;6(8):619-26. doi: 10.4161/hv.6.8.11563.

Controlling influenza by cytotoxic T-cells: calling for help from destroyers.

J Biomed Biotechnol. 2010;2010:863985. doi: 10.1155/2010/863985. Epub 2010 May 24.

本文引用的文献

Update: influenza vaccine supply and recommendations for prioritization during the 2005-06 influenza season.

MMWR Morb Mortal Wkly Rep. 2005 Sep 2;54(34):850.

Vaccine supply: a cross-national perspective.

Health Aff (Millwood). 2005 May-Jun;24(3):706-17. doi: 10.1377/hlthaff.24.3.706.